Astrazeneca Ab v European Commission, European Federation Of Pharmaceutical Industries And Associations: ECJ 6 Dec 2012

ECJ Appeals – Competition – Abuse of dominant position – Market in anti-ulcer medicines – Abuse of procedures relating to supplementary protection certificates for medicinal products and of marketing authorisation procedures for medicinal products – Misleading representations – Deregistration of marketing authorisations – Obstacles to the marketing of generic medicinal products and to parallel imports

Citations:

C-457/10, [2012] EUECJ C-457/10

Links:

Bailii

Statutes:

Directive 65/65/EEC, Regulation (EEC) No 1768/92

Jurisdiction:

European

European

Updated: 12 November 2022; Ref: scu.467080